The role of GLP-1 receptor agonists in IBD-related surgery and IBD-related complications of inflammatory bowel disease among patients with metabolic comorbidities: a systematic review and meta-analysis
BackgroundGlucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for type 2 diabetes and obesity, and emerging evidence suggests potential immunomodulatory effects. However, few studies have evaluated their role in inflammatory bowel disease (IBD), and no comprehensive clinical trials...
Saved in:
| Main Authors: | Mengqi Yang, Yujia Huo, Zhining Liu, Guannan Bai, Dongjun He, Lin Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1621958/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01) -
The impact of diet on the inflammatory bowel disease course – a literature review
by: Agnieszka Nowotarska, et al.
Published: (2024-11-01) -
Clinical Predictive Factors of Response to Biologics in IBD
by: Roxana SADAGURSCHI, et al.
Published: (2022-03-01) -
The IBD-DCA score in the pathological assessment of ulcerative colitis and Crohn’s disease: observations from a single-center experience
by: José de Ribamar Barroso Jucá Neto, et al.
Published: (2025-08-01) -
Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
by: A. I. Akinshina, et al.
Published: (2019-05-01)